Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry

Manasi Agrawal, Erica J. Brenner, Xian Zhang, Irene Modesto, John Woolcott, Ryan C. Ungaro, Jean Frederic Colombel, Michael D. Kappelman

Research output: Contribution to journalArticlepeer-review

41 Scopus citations
Original languageEnglish
Pages (from-to)585-589
Number of pages5
JournalInflammatory Bowel Diseases
Volume27
Issue number4
DOIs
StatePublished - 1 Apr 2021

Keywords

  • Crohn's disease
  • coronavirus disease 2019
  • inflammatory bowel disease
  • outcomes
  • tofacitinib
  • ulcerative colitis

Cite this